DJ warns of fat jab perils after freak accident leaves her with 'old lady bones'
Sophie Wright, 35, a former professional ice skater turned writer and DJ, was diagnosed with severe osteoporosis after snapping her thigh bone in a fall doctors say should never have caused such damage.
She said: "I landed on a straight leg and snapped my thigh. The femur is the biggest and hardest bone in your body to break. The surgeon asked if I'd been in a car crash because it was such a high-impact injury."
A DEXA scan revealed Sophie's bones were dangerously brittle.
She explained: "I couldn't have scored any lower. I'm essentially made of glass at this point."
Although she has never taken popular weight-loss jabs like Ozempic, Wegovy or Mounjaro, her experience has made her deeply suspicious of the booming craze for slimming injections.
Sophie said: "I'm sure as hell staying away from Ozempic-like jabs. Bone health had never entered my mind... It's what your nan might talk about."
Doctors say Sophie's fears are not unfounded. The powerful appetite-suppressing drugs – originally created to manage type 2 diabetes – are now being widely used for fast-track weight loss, but studies suggest they may come at a dangerous cost to bone health.
As appetite and food intake fall, so do essential nutrients like calcium and vitamin D, putting users at risk of fractures and even visible height loss. Some patients have reportedly shrunk by as much as two inches.
Dr. Doug Lucas, a metabolic health expert, said the risks could be "potentially catastrophic" for many users.
He explained: "A higher percentage of weight lost using jabs is lean mass – from both muscle and bone.
"These are critical tissues for long-term health. With tens of millions of adults now using these drugs, the consequences could be widespread."
Sophie's accident changed her life. She required surgery to rebuild her femur and now has permanent metalwork in her leg.
She explained: "I still can't fully bend my leg. But I know I'm not normal because a healthy woman of 35 should not be shattering her bones like this."
To add to the shock, Sophie was also diagnosed with diabetes – the very illness the injections are meant to treat. Despite being a textbook candidate for the jabs, she's decided the risk is too high.
She said: "I considered Ozempic to help manage my blood sugar. But now I just think no. Not worth the risk."
Doctors say anyone considering weight-loss jabs should be properly monitored, and stress the importance of strength training and a diet rich in bone-friendly nutrients.
One specialist said: "Losing weight doesn't have to come at the cost of your skeleton."
For Sophie, the warning has come too late – but she hopes others will think twice before jumping on the jab bandwagon.
She said: "I'm essentially made of glass at this point.
"And no one told me this could happen."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
12 hours ago
- News.com.au
Aid groups warn of starving children as European powers discuss Gaza
Aid groups warned of surging numbers of malnourished children in war-ravaged Gaza as a trio of European powers prepared to hold an "emergency call" Friday on the deepening humanitarian crisis. Doctors Without Borders (MSF) said that a quarter of the young children and pregnant or breastfeeding mothers it had screened at its clinics last week were malnourished, a day after the United Nations said one in five children in Gaza City were suffering from malnutrition. With fears of mass starvation growing, Britain, France and Germany were set to hold an emergency call to push for a ceasefire between Israel and Hamas and discuss steps towards Palestinian statehood. "I will hold an emergency call with E3 partners tomorrow, where we will discuss what we can do urgently to stop the killing and get people the food they desperately need while pulling together all the steps necessary to build a lasting peace," British Prime Minister Keir Starmer said. The call comes after hopes of a new ceasefire in Gaza faded on Thursday when Israel and the United States quit indirect negotiations with Hamas in Qatar. US envoy Steve Witkoff accused the Palestinian militant group of not "acting in good faith". President Emmanuel Macron said Thursday that France would formally recognise a Palestinian state in September, drawing a furious rebuke from Israel. - 'Mass starvation' - More than 100 aid and human rights groups warned this week that "mass starvation" was spreading in Gaza. Israel has rejected accusations it is responsible for the deepening crisis, which the World Health Organization has called "man-made". Israel placed the Gaza Strip under an aid blockade in March, which it only partially eased two months later. The trickle of aid since then has been controlled by the Israeli- and US-backed Gaza Humanitarian Foundation, replacing the longstanding UN-led distribution system. Aid groups have refused to work with it, accusing it of aiding Israeli military goals. The GHF system, in which Gazans have to travel long distances and join huge queues to reach one of four sites, has often proved deadly, with the UN saying that more than 750 Palestinian aid-seekers have been killed by Israeli forces near GHF centres since late May. An AFP photographer saw bloodied patients, wounded while attempting to get humanitarian aid, being treated on the floor of Nasser hospital in the southern city of Khan Yunis on Thursday. Israel has refused to return to the UN-led system, saying that it allowed Hamas to hijack aid for its own benefit. Accusing Israel of the "weaponisation of food", MSF said that: "Across screenings of children aged six months to five years old and pregnant and breastfeeding women, at MSF facilities last week, 25 per cent were malnourished." It said malnutrition cases had quadrupled since May 18 at its Gaza City clinic and that the facility was enrolling 25 new patients every day. Aid groups and medics have also warned that a lack of food is preventing the sick and wounded from recovering. - 'High risk of dying' - On Thursday, the UN agency for Palestinian refugees (UNRWA) said that one in five children in Gaza City were malnourished. Agency chief Philippe Lazzarini said: "Most children our teams are seeing are emaciated, weak and at high risk of dying if they don't get the treatment they urgently need." He also warned that "UNRWA frontline health workers, are surviving on one small meal a day, often just lentils, if at all". Lazzarini said that the agency had "the equivalent of 6,000 loaded trucks of food and medical supplies" ready to send into Gaza if Israel allowed "unrestricted and uninterrupted" access to the territory. Israel's military campaign in Gaza has killed 59,587 Palestinians, mostly civilians, according to the health ministry in the Hamas-run territory. Hamas's October 2023 attack that triggered the war resulted in the deaths of 1,219 people, most of them civilians, according to an AFP tally based on official figures. Of the 251 hostages taken during the attack, 49 are still being held in Gaza, including 27 the Israeli military says are dead.
West Australian
a day ago
- West Australian
Kieran Le Plastrier: Quit moralising and embrace the potential of weight loss drugs
It's rare in medicine to witness a single class of drugs redefine the boundaries of treatment across multiple chronic diseases. Yet that's precisely what we're seeing with GLP-1 receptor agonists — commonly known by brand names including Ozempic and Mounjaro. Initially developed as a treatment for diabetes, these drugs are now proving to be nothing short of transformative for millions of people worldwide. But while their potential is vast, our access to them remains frustratingly narrow. There's a common misconception that these drugs are only a tool for weight loss and diabetes management. But that's far from the limit of their potential. These medications are showing promise in reducing the risk of heart disease, stroke, kidney failure, liver disease, and even dementia. They're also being explored as tools to combat addiction — blunting the brain's reward system and helping people overcome dependencies on alcohol, nicotine, and other substances. We are standing at the edge of a paradigm shift in how we treat chronic disease. Yet in Australia, access to these drugs is largely restricted to people with uncontrolled diabetes at a subsidised cost under the Pharmaceutical Benefits Scheme. While they can be prescribed off-label for other conditions, such as obesity, without the PBS subsidy the cost can be anything from $55 to $130 a dose, which most people simply can't afford. Obesity is not a personal moral failing. It is a complex, multi-factorial condition driven by genetics, environment, and a society that promotes sedentary lifestyles and calorie-dense foods. We live in an obesogenic world, and blaming individuals for their biology is both unjust and ineffective. The UK's NHS has already recognised this, moving to subsidise GLP-1 drugs for people with obesity to reduce long-term disease burden. Australia must follow suit. The cost of inaction — measured in heart attacks, strokes, hospital admissions, and lives lost — is far greater than the cost of these medications. Now, these drugs are not a silver bullet. They work best as part of a holistic approach that includes dietary support, physical activity, and psychological care. And as for every powerful therapeutic drug, risks exist and must be carefully considered and managed under the care of expert health practitioner But they offer something we've never had before: a safer, effective, and scalable way to intervene in the metabolic cascade that underpins so many of our modern diseases. We need to stop treating these drugs as luxury items for the wealthy or as quick fixes for vanity. They are powerful tools for prevention and healing. It's time our health system caught up with the science. Dr Kieran Le Plastrier is a GP and Assistant Professor of General Practice at Bond University
Perth Now
2 days ago
- Perth Now
Five things you should know before having a weight loss jab
GLP-1 medications are a major breakthrough for people to shed pounds and manage conditions such as Type 2 diabetes. However, doctors say there's a perception that weight-loss drugs such as semaglutide (brand names Ozempic and Wegovy) and tirzepatide (Mounjaro) are all you need to live a healthier life. Diet and exercise still matter, said JoAnn Manson, chief of the division of preventive medicine at Brigham and Women's Hospital in Boston. 'They remain crucial,' Dr Manson said. 'If you're not paying attention to protein intake, hydration and having regular physical activity — especially resistance training — you can end up with poor nutritional status and substantial muscle loss.' GLP-1 drugs mimic a hormone the body produces to regulate hunger and blood sugar. The injections cut cravings for food, slow digestion and keep people feeling full for longer periods of time. However, since the drugs affect the stomach's functions, they also can cause gastrointestinal side effects such as nausea and vomiting. Some people stop taking the drugs because of these gut symptoms. Still, Dr Manson said, with some 'relatively straightforward' changes in behaviour, people can minimise these problems and continue using the drug. Dr Manson is a co-author of two articles — one for clinicians and another for patients — that were recently published in JAMA Internal Medicine. Here are five things Dr Manson and her co-authors want people on these medications to know. These medications can help someone lose around 15 to 21 per cent of their body weight. But a significant portion of that weight - up to one-fourth - can be lean body mass and muscle, Dr Manson said. This protein can come from chicken, fish, beans, chickpeas or tofu, Dr Manson said. Aim for 1 to 1.5 grams of protein each day per kilogram (2.2 pounds) of body weight. If you don't have an appetite or are eating smaller meals, you may want to try drinking a protein shake throughout the day as a supplement. Dr Manson and her co-authors suggest filling a plate this way: half fruits and vegetables, one-quarter protein, and the rest whole grains. You can strengthen your muscles with bands, weights and body-weight exercises to counteract the potential loss in lean body mass, Dr Manson said. Aim for 60 to 90 minutes of resistance training and 150 minutes of aerobic exercise, such as brisk walking, per week. Water can help with the dehydration and constipation associated with the weight-loss drugs, said Dr Manson, who recommended 8 to 12 glasses per day. You also can eat water-rich foods such as cucumbers and watermelon to stay hydrated. And the researchers recommend that people on GLP-1 drugs limit their intake of alcohol, caffeine, and sugary or artificially sweetened beverages. This may help reduce your risk of heartburn. Add fibre to help with constipation, and avoid high-fat foods - or fried foods - because they can worsen feelings of nausea. Andres J Acosta, an associate professor of medicine and a consultant in gastroenterology and hepatology at the Mayo Clinic, who has also consulted for Novo Nordisk and Eli Lilly, and has co-founded two weight-loss-associated companies, Phenomix Sciences and Gila Therapeutics, said he often finds that patients have a 'preconceived notion' that they just need to take the medication and they'll lose weight. But the clinical trials for these weight-loss drugs included 'comprehensive programs' with lifestyle interventions for a calorie-reduced diet and exercise program. 'This perception — just take the shot and don't do anything else - is wrong. It's not going to drive real, long-term behavioural changes,' said Professor Acosta, who is a co-author of The Mayo Clinic Diet: Weight-Loss Medications Edition. 'Patients aren't going to see the outcomes that we're seeing in the trials.' The GLP-1 medications are one tool in a broader weight-management program, Professor Acosta said. He tells people they still need to have a healthy diet, with 'a good amount of protein' and enough water to stay well hydrated. 'I like to set the expectations from the get-go,' Professor Acosta said. 'And I also tell them that not everyone is going to lose weight.' Some people will gain back weight when they stop taking these medications, said Elizabeth Mietlicki-Baase, an associate professor of exercise and nutrition sciences at the University of Buffalo. Researchers are interested in 'finding strategies to prevent weight regain after discontinuation,' she said. 'But we don't have a great handle on that just yet.' (c) 2025 , The Washington Post
